Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
Latitude™ MRD Assay
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Natera
Type:
Laboratory Developed Test
Related tests:
‹
Signatera™ (2)
Altera
Empower™ Hereditary cancer test
Ultra-Sensitive Signatera™ Genome MRD Test
Signatera™ (2)
Altera
Empower™ Hereditary cancer test
Ultra-Sensitive Signatera™ Genome MRD Test
›
Details
Evidence
News
Filter by
Latest
5ms
Natera Presents Data at ESMO GI on its Tissue-Free Latitude™ MRD* Assay, Demonstrating Excellent Overall Performance in Colorectal Cancer (Natera Press Release)
" Natera, Inc...announced data from a colorectal cancer (CRC) study of its tissue-free Latitude™ MRD assay, which were presented at the 2025 European Society for Medical Oncology GI Congress (ESMO GI)."
5 months ago
Clinical data
|
Latitude™ MRD Assay
Share
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.